FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

More ANDA Bioequivalence Draft Guides Posted

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances for generic drug developers.

latest-news-card-1
Human Drugs

Require Generic Ozobax Safety Data: Metacel

Metacel says FDA must require sponsors of generic Ozobax to perform and submit the same flavoring safety data that Metacel was required to submit.

latest-news-card-1
Human Drugs

FDA Reorg Could Hurt Supplements: Duncan

South Carolina GOP Rep. Jeff Duncan says FDA should retain the Office of Dietary Supplement Programs as a freestanding entity rather than merging it i...

Biologics

FDA Approves RSV Vaccine for Pregnant Women

FDA approves Pfizers RSV vaccine Abrysvo for use in pregnant women to protect infants from birth to 6 months of age.

latest-news-card-1
Medical Devices

Nurami Dura Mater Repair Graft Cleared

FDA clears a Nurami Medical 510(k) for its ArtiFascia Dura Substitute, a resorbable dura mater repair graft.

latest-news-card-1
FDA General

Drug Shortages are National Security Risk: Califf

FDA commissioner Robert Califf tells an Alliance for a Stronger FDA webinar that ongoing drug shortages are a huge national security risk and better i...

Marketing

OPDP Cites Exeltis Promos on Social Media

CDER Office of Prescription Drug Promotion cites Exeltis USA for making false or misleading claims in a social media post.

latest-news-card-1
Human Drugs

Device Cybersecurity Guide Coming by 9/30: FDA

FDA plans to finalize by 9/30 its draft guidance entitled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Sub...

latest-news-card-1
Human Drugs

Eylea OKd After Fixing Inspection Findings

Regeneron Pharmaceuticals wins FDA approval for high-dose Eylea HD (aflibercept) injection 8 mg after resolving inspection concerns at its contract ma...

latest-news-card-1
Human Drugs

FDA Approves Ingrezza for Huntingtons Chorea

FDA approves a Neurocrine Biosciences NDA for Ingrezza (valbenazine) capsules for treating adults with chorea associated with Huntingtons disease.